The Centenary Institute’s Professor Warwick Britton AO has hosted the informal launch of the new NHMRC Centre for Research Excellence in Tuberculosis Control on Both Sides of Our Border (TB-CRE).
In August, the TB-CRE secured $2.5 million in NHMRC funding to operate as an interdisciplinary centre of research excellence over five years.
Held at the Centenary Institute last week, all of the Centre’s Chief and Associate Investigators gathered to plan the future directions of the TB-CRE, ahead of its formal launch at the 2019 TB-CRE Symposium in May.
Diagnostic tests and a vaccine for tuberculosis have been available for more than 100 years, while effective drugs have been available for more than 60 years.
Despite this, tuberculosis remains the world’s deadliest infectious disease.
The TB-CRE is focused on:
You can read more about the TB-CRE on its website.
Centenary Institute scientists have conducted a study which could change how researchers discover the causes of genetic heart disease.
Centenary's Professor Mark Gorrell has been involved in a study, which has developed a new way to monitor ovarian cancer growth.
An image taken by Dr Ka Ka Ting has featured on the frontcover of scientific journal Diabetologia.